Particle size characterization in nanosuspensions often focuses on ‘majority’ features of the size distribution. Yet, for various suspensions in (bio)pharmaceuticals or fine chemicals, small fractions ...

One of the fundamental purposes of biotherapeutic research, development, and production is to assure the safety and efficacy of medicinal products in clinical settings. Analytical tools are critical ...

Layered drug nanoparticles can now be produced efficiently and at scale using a microfluidic method that eliminates purification and improves consistency. Since its adaptation to nanoscale materials, ...

Active principle ingredients (API) and protein aggregation are of the utmost importance when ensuring the usability and stability of injectable biopharmaceutical products. Protein aggregation is a ...

To ensure the stability and usability of injectable biopharmaceutical products, protein aggregation and active principle ingredients (API) are of the utmost concern. Protein aggregation is a process ...

In biotherapeutic development, hitting roadblocks due to insufficient developability assessment is a common and costly setback. Traditional particle analysis methods demand more sample volume than is ...